CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 67 filers reported holding CTI BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $64,000 | +120.7% | 157,381 | +83.7% | 0.00% | – |
| Q2 2016 | $29,000 | -56.1% | 85,665 | -31.7% | 0.00% | – |
| Q1 2016 | $66,000 | -93.3% | 125,400 | -84.4% | 0.00% | – |
| Q4 2015 | $990,000 | -12.9% | 804,297 | +3.3% | 0.00% | – |
| Q3 2015 | $1,136,000 | -29.4% | 778,615 | -5.7% | 0.00% | – |
| Q2 2015 | $1,610,000 | -23.8% | 825,372 | -29.3% | 0.00% | -100.0% |
| Q1 2015 | $2,113,000 | +2.9% | 1,167,321 | +34.2% | 0.00% | – |
| Q4 2014 | $2,053,000 | +98.2% | 869,738 | +103.2% | 0.00% | – |
| Q3 2014 | $1,036,000 | -47.8% | 428,100 | -39.4% | 0.00% | -100.0% |
| Q2 2014 | $1,986,000 | – | 707,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,425,000 | $3,363,000 | 2.66% |
| ACUTA CAPITAL PARTNERS, LLC | 1,228,111 | $2,898,000 | 1.96% |
| Sio Capital Management, LLC | 505,000 | $1,192,000 | 0.94% |
| RA Capital Management | 2,500,000 | $5,900,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,000 | $1,770,000 | 0.30% |
| TFS CAPITAL LLC | 1,295,744 | $3,058,000 | 0.29% |
| EAGLE ASSET MANAGEMENT INC | 12,713,051 | $30,002,000 | 0.17% |
| JW Asset Management, LLC | 52,271 | $123,000 | 0.09% |
| Lombard Odier Asset Management (USA) Corp | 501,444 | $1,183,000 | 0.08% |
| First Heartland Consultants, Inc. | 74,624 | $176,000 | 0.07% |